Company Search:
Advanced Search
Sponsored Links
Physiomics PLC Company Snapshot
Physiomics PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Physiomics PLC with three other companies in this sector in UNITED KINGDOM : Shield Therapeutics PLC (2019 sales of £719,000.00 [US$898,750.00 ] of which 100% was Feraccru), Midatech Pharma PLC (£674,000.00 [US$842,500.00 ] of which 100% was Pipeline R&D), and Integumen PLC (£823,000.00 [US$1.03 million] ).

Sales Analysis. During the year ended June of 2019, sales at Physiomics PLC were £718,965.00 (US$898.71 thousand). This is an increase of 67.9% versus 2018, when the company's sales were £428,277.00 .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Physiomics PLC
  Stock Performance Chart for Physiomics PLC
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 6.35p
(Figures in Pounds Sterling)
1 Week 27.0%   13 Weeks 39.6%  
4 Weeks 284.8%   52 Weeks 108.2%  
Physiomics PLC Key Data:
  Ticker: PYC Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 718,965
(Year Ending Jan 2020).
Employees: 7
  Currency: Pounds Sterling Market Cap: 4,566,310
  Fiscal Yr Ends: June Shares Outstanding: 71,910,394
  Share Type: Ordinary Closely Held Shares: 7,577,832
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.